semaglutide medicine for weight loss Half of Patients Stop by 1 Year Weight Loss by Patiently |

PlexusDx has no affiliate relationship, sponsorship, or commercial tie to Eden or its parent company

Personalization: Finding Your Optimal GLP-1 Therapy The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways

Scientifically supported claims approved by Health Canada

However, without integration with behavioral medicine and lifestyle changes, these benefits will likely end when patients stop taking GLP-1 medications

Semaglutide-based GLP-1s include Ozempic (diabetes medication), Rybelsus (diabetes), and Wegovy (weight loss medication)

Commercial teams could incentivize providers to use these tools by offering bonus programs or faster co-pay assistance